EAN NewsInterviewsTop Articles
Video Interview: EMA approval of lecanemab, with Sebastiaan Engelborghs, EAN Dementia Panel Co-Chair
Sebastiaan Engelborghs, Co-Chair of the EAN Scientific Panel on Dementia & Cognitive Disorders talks to EAN Communications Committee member Raphael Wurm about the recent decision by the European Medicines Agency to approve lecanemab for Alzheimer’s disease treatment.